Elsa Berardi

589 total citations
23 papers, 401 citations indexed

About

Elsa Berardi is a scholar working on Epidemiology, Hepatology and Surgery. According to data from OpenAlex, Elsa Berardi has authored 23 papers receiving a total of 401 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Epidemiology, 8 papers in Hepatology and 6 papers in Surgery. Recurrent topics in Elsa Berardi's work include Liver Disease Diagnosis and Treatment (9 papers), Liver Disease and Transplantation (6 papers) and Hepatocellular Carcinoma Treatment and Prognosis (3 papers). Elsa Berardi is often cited by papers focused on Liver Disease Diagnosis and Treatment (9 papers), Liver Disease and Transplantation (6 papers) and Hepatocellular Carcinoma Treatment and Prognosis (3 papers). Elsa Berardi collaborates with scholars based in Italy, United States and China. Elsa Berardi's co-authors include Carlo Sabbà, Paolo Buonamico, O Albano, Giuseppina Piazzolla, Gregorio Brevetti, Giovanna Ferraioli, Kenneth J. W. Taylor, Stefano Perna, Antonio Moschetta and Lucilla Crudele and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Hepatology.

In The Last Decade

Elsa Berardi

22 papers receiving 382 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Elsa Berardi Italy 10 187 132 116 72 58 23 401
Antony M. Wheatley New Zealand 12 216 1.2× 143 1.1× 402 3.5× 66 0.9× 35 0.6× 17 635
Daisuke Kanda Japan 12 101 0.5× 76 0.6× 101 0.9× 39 0.5× 38 0.7× 55 371
Jildou Hoekstra Netherlands 6 157 0.8× 206 1.6× 170 1.5× 19 0.3× 27 0.5× 9 378
A. Hadengue France 12 286 1.5× 345 2.6× 146 1.3× 85 1.2× 39 0.7× 36 577
Takayoshi Yokoyama Japan 10 84 0.4× 184 1.4× 279 2.4× 113 1.6× 16 0.3× 47 535
B.C. Jaques United Kingdom 10 50 0.3× 88 0.7× 305 2.6× 102 1.4× 46 0.8× 20 484
Takumi Akiyama Japan 12 272 1.5× 249 1.9× 163 1.4× 126 1.8× 54 0.9× 25 534
Mario Plebani Italy 8 71 0.4× 68 0.5× 91 0.8× 48 0.7× 24 0.4× 11 357
Jonas Valantinas Lithuania 12 146 0.8× 128 1.0× 142 1.2× 63 0.9× 9 0.2× 42 395
F.J. Carrilho Brazil 7 276 1.5× 288 2.2× 163 1.4× 118 1.6× 75 1.3× 21 521

Countries citing papers authored by Elsa Berardi

Since Specialization
Citations

This map shows the geographic impact of Elsa Berardi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elsa Berardi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elsa Berardi more than expected).

Fields of papers citing papers by Elsa Berardi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elsa Berardi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elsa Berardi. The network helps show where Elsa Berardi may publish in the future.

Co-authorship network of co-authors of Elsa Berardi

This figure shows the co-authorship network connecting the top 25 collaborators of Elsa Berardi. A scholar is included among the top collaborators of Elsa Berardi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elsa Berardi. Elsa Berardi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Petruzzelli, Stefano, et al.. (2025). Improving cardiovascular risk stratification: the role of abdominal obesity in predicting MACEs. Cardiovascular Diabetology. 24(1). 328–328. 2 indexed citations
2.
Berardi, Elsa, et al.. (2025). Reduced serum iron levels are associated with metabolic dysfunction and sex-specific characteristics. Internal and Emergency Medicine. 21(1). 129–139.
3.
Crudele, Lucilla, Raffaella Maria Gadaleta, Marica Cariello, et al.. (2024). Hyperhomocysteinemia is linked to MASLD. European Journal of Internal Medicine. 131. 49–57. 6 indexed citations
4.
Crudele, Lucilla, et al.. (2024). Fatty Liver Index (FLI) is the best score to predict MASLD with 50% lower cut-off value in women than in men. Biology of Sex Differences. 15(1). 43–43. 25 indexed citations
5.
Crudele, Lucilla, Stefano Petruzzelli, Patrizia Suppressa, et al.. (2023). Thyroid nodule malignancy is associated with increased non-invasive hepatic fibrosis scores in metabolic subjects. Frontiers in Oncology. 13. 1233083–1233083. 4 indexed citations
6.
Crudele, Lucilla, Elena Piccinin, Raffaella Maria Gadaleta, et al.. (2022). Low HDL-cholesterol levels predict hepatocellular carcinoma development in individuals with liver fibrosis. JHEP Reports. 5(1). 100627–100627. 46 indexed citations
7.
Cariello, Marica, Sara Simonelli, Alice Ossoli, et al.. (2021). Abdominal obesity negatively influences key metrics of reverse cholesterol transport. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1867(2). 159087–159087. 9 indexed citations
8.
Battaglia, Stefano, Elsa Berardi, Patrizia Suppressa, et al.. (2020). Gender, BMI and fasting hyperglycaemia influence Monocyte to-HDL ratio (MHR) index in metabolic subjects. PLoS ONE. 15(4). e0231927–e0231927. 21 indexed citations
9.
Sangineto, Moris, et al.. (2020). Analysis of hepatic stiffness after viral eradication in a population with chronic hepatitis C treated with DAAs. Medicina Clínica. 156(7). 317–323. 4 indexed citations
10.
Piazzolla, Giuseppina, Mafalda Candigliota, Margherita Fanelli, et al.. (2019). Hyperhomocysteinemia is an independent risk factor of atherosclerosis in patients with metabolic syndrome. Diabetology & Metabolic Syndrome. 11(1). 87–87. 34 indexed citations
11.
Piazzolla, Giuseppina, Margherita Fanelli, Antonio Mazzocca, et al.. (2017). Metabolic syndrome and Chronic Obstructive Pulmonary Disease (COPD): The interplay among smoking, insulin resistance and vitamin D. PLoS ONE. 12(10). e0186708–e0186708. 43 indexed citations
12.
Barone, M., et al.. (2015). Liver stiffness and portal blood flow modifications induced by a liquid meal consumption: pathogenetic mechanisms and clinical relevance. Scandinavian Journal of Gastroenterology. 50(5). 560–566. 14 indexed citations
13.
Sabbà, Carlo, Paolo Buonamico, Gianluigi Vendemiale, et al.. (2001). Haemodynamic effects of propranolol, octreotide and their combination during fasting and post-prandial splanchnic hyperaemia in patients with cirrhosis. European Journal of Gastroenterology & Hepatology. 13(2). 163–169. 12 indexed citations
14.
Buonamico, Paolo, Carlo Sabbà, Guadalupe García–Tsao, et al.. (1995). Octreotide blunts postprandial splanchnic hyperemia in cirrhotic patients: A double-blind randomized echo-doppler study. Hepatology. 21(1). 134–139. 59 indexed citations
15.
Sabbà, Carlo, Elsa Berardi, Giovanna Ferraioli, et al.. (1994). Comparison between the effect of L-propionylcarnitine, L-acetylcarnitine and nitroglycerin in chronic peripheral arterial disease: a haemodynamic double blind echo-Doppler study. European Heart Journal. 15(10). 1348–1352. 6 indexed citations
16.
17.
Sabbà, Carlo, Giovanna Ferraioli, Paolo Buonamico, et al.. (1992). Echo-Doppler evaluation of acute flow changes in portal hypertensive patients: flow velocity as a reliable parameter. Journal of Hepatology. 15(3). 356–360. 33 indexed citations
18.
Berardi, Elsa, et al.. (1991). Accuracy of echo-Doppler flowmetry for renal artery stenosis. Journal of Hypertension. 9(6). S242–S242. 2 indexed citations
19.
Sabbà, Carlo, Elsa Berardi, Paolo Buonamico, et al.. (1991). Accuracy of echo-Doppler flowmetry for renal artery stenosis. Journal of Hypertension. 9. S242–S242. 1 indexed citations
20.
Sabbà, Carlo, et al.. (1984). [Influence of metabolic equilibrium on erythrocyte deformability in diabetes mellitus].. PubMed. 60(10). 1853–8. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Antony M. Wheatley Breakdown of academic impact, for papers by Daisuke Kanda Breakdown of academic impact, for papers by Jildou Hoekstra Breakdown of academic impact, for papers by A. Hadengue Breakdown of academic impact, for papers by Takayoshi Yokoyama Breakdown of academic impact, for papers by B.C. Jaques Breakdown of academic impact, for papers by Takumi Akiyama Breakdown of academic impact, for papers by Mario Plebani Breakdown of academic impact, for papers by Jonas Valantinas Breakdown of academic impact, for papers by F.J. Carrilho
Rankless by CCL
2026